ProfileGDS5678 / 1419998_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 49% 48% 48% 46% 47% 50% 49% 48% 47% 48% 48% 47% 48% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2129649
GSM967853U87-EV human glioblastoma xenograft - Control 23.1363148
GSM967854U87-EV human glioblastoma xenograft - Control 33.1373448
GSM967855U87-EV human glioblastoma xenograft - Control 43.0290446
GSM967856U87-EV human glioblastoma xenograft - Control 53.0489947
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2880450
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.253549
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1192148
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0756647
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1126148
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1409548
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0688647
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1586248
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1389248